Difficulty: Medium
Average Score: 71%
Practice
A client is prescribed Bethanechol to treat urinary retention. Which of the following findings is a manifestation of muscarinic stimulation?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Excessive perspiration. Bethanechol is a muscarinic receptor agonist, which means it stimulates muscarinic receptors in the body. Muscarinic receptors are found in various organs, including sweat glands. Stimulation of these receptors by Bethanechol would lead to an increase in sweating, hence excessive perspiration is a manifestation of muscarinic stimulation.
Now, let's analyze why the other options are incorrect:
A) Dry mouth: Dry mouth is a common side effect of anticholinergic drugs, not muscarinic agonists like Bethanechol.
B) Hypertension: Muscarinic stimulation typically does not lead to hypertension. In fact, activation of muscarinic receptors can cause vasodilation and a decrease in blood pressure.
D) Fecal impaction: Fecal impaction is not directly related to muscarinic stimulation by Bethanechol.
In an educational context, understanding the effects of medications on specific receptors is crucial for safe and effective pharmacological practice. By knowing the expected outcomes of muscarinic stimulation, healthcare professionals can anticipate and manage potential side effects or therapeutic responses in patients taking medications like Bethanechol for urinary retention.
Now, let's analyze why the other options are incorrect:
A) Dry mouth: Dry mouth is a common side effect of anticholinergic drugs, not muscarinic agonists like Bethanechol.
B) Hypertension: Muscarinic stimulation typically does not lead to hypertension. In fact, activation of muscarinic receptors can cause vasodilation and a decrease in blood pressure.
D) Fecal impaction: Fecal impaction is not directly related to muscarinic stimulation by Bethanechol.
In an educational context, understanding the effects of medications on specific receptors is crucial for safe and effective pharmacological practice. By knowing the expected outcomes of muscarinic stimulation, healthcare professionals can anticipate and manage potential side effects or therapeutic responses in patients taking medications like Bethanechol for urinary retention.